Library
PubMed
research article
Professional

Characteristics and outcome of intra-abdominal desmoid-type fibromatosis.

Source: PubMed, NCBI / U.S. National Library of Medicine

European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical OncologyPenel Nicolas, Toulmonde Maud, Wallet Jennifer, et al.Published 5/19/2026Last synced 5/24/2026Status: syncedPMID: 42173035DOI: 10.1016/j.ejso.2026.111903

Data about intra-abdominal desmoid-type fibromatosis (IA-DTFs) are limited. We examined patients with IA-DTFs enrolled in the ALTITUDES study (NCT02867033). We compared their characteristics with those of other locations using chi-square and Wilcoxon tests, as appropriate, and assessed their outcomes using event-free survival (EFS). Association between primary location and EFS was determined using a Cox univariate model. Subgroup analysis was performed for patients initially managed with active surveillance (AS). 95/610 tumors (15.5%) enrolled in ALTITUDES were intra-abdominal. Compared with other locations, patients with IA-DTFs were older (p&#xa0;<&#xa0;0.001), more often men (p&#xa0;<&#xa0;0.001), had more frequently a history of polyposis (p&#xa0;=&#xa0;0.001), larger tumors (p&#xa0;=&#xa0;0.003), different CTNNB1 mutation profiles (p&#xa0;=&#xa0;0.004), and a diagnosis established more frequently on surgical specimens (p&#xa0;<&#xa0;0.001). These patients reported less pain (p&#xa0;=&#xa0;0.01) and fewer emotional difficulties (p&#xa0;=&#xa0;0.001), but more constipation (p&#xa0;=&#xa0;0.004). Surgery was the most common first-line approach (51.6%); AS accounted for the management of only 29.5%. Overall, we observed no significant difference between IA-DTFs and other locations in terms of EFS (hazard ratio, HR&#xa0;=&#xa0;0.84; 95%CI, 0.56-1.26) and overall survival (HR&#xa0;=&#xa0;1.84; 0.50-6.80). Among patients managed by AS, EFS was similar between both groups (HR&#x

Abstract

Data about intra-abdominal desmoid-type fibromatosis (IA-DTFs) are limited. We examined patients with IA-DTFs enrolled in the ALTITUDES study (NCT02867033). We compared their characteristics with those of other locations using chi-square and Wilcoxon tests, as appropriate, and assessed their outcomes using event-free survival (EFS). Association between primary location and EFS was determined using a Cox univariate model. Subgroup analysis was performed for patients initially managed with active surveillance (AS). 95/610 tumors (15.5%) enrolled in ALTITUDES were intra-abdominal. Compared with other locations, patients with IA-DTFs were older (p&#xa0;<&#xa0;0.001), more often men (p&#xa0;<&#xa0;0.001), had more frequently a history of polyposis (p&#xa0;=&#xa0;0.001), larger tumors (p&#xa0;=&#xa0;0.003), different CTNNB1 mutation profiles (p&#xa0;=&#xa0;0.004), and a diagnosis established more frequently on surgical specimens (p&#xa0;<&#xa0;0.001). These patients reported less pain (p&#xa0;=&#xa0;0.01) and fewer emotional difficulties (p&#xa0;=&#xa0;0.001), but more constipation (p&#xa0;=&#xa0;0.004). Surgery was the most common first-line approach (51.6%); AS accounted for the management of only 29.5%. Overall, we observed no significant difference between IA-DTFs and other locations in terms of EFS (hazard ratio, HR&#xa0;=&#xa0;0.84; 95%CI, 0.56-1.26) and overall survival (HR&#xa0;=&#xa0;1.84; 0.50-6.80). Among patients managed by AS, EFS was similar between both groups (HR&#xa0;=&#xa0;1.05; 0.55-2.00). One third of IA-DTFs patients were managed using AS, and their outcome was similar to those of patients with other locations. These observational data may help to discuss SA as a first-line approach in the management of IA-DTFs patients.

Educational only
This information is for general education and is not medical advice. Always talk to a licensed U.S. clinician about your situation, medications, or treatment decisions.